Pneumonia Diagnosis and Treatment

Diagnostic Criteria

The presence of fever (≥38°C), pleural pain, dyspnea, tachypnea, and abnormal chest examination findings strongly suggest pneumonia, according to the American College of Chest Physicians 1
C-reactive protein (CRP) measurement strengthens diagnosis when >30 mg/L, as recommended by the American College of Chest Physicians 1
Absence of runny nose with presence of breathlessness, crackles, diminished breath sounds, tachycardia, and fever suggests pneumonia, as suggested by the American College of Chest Physicians 1

Routine microbiological testing is not recommended unless results would change therapy, as stated by the American College of Chest Physicians 1
Antibiotics should not be prescribed when viral etiology is more likely (absence of fever, normal vital signs, normal lung exam), according to the American College of Chest Physicians 1
The European Respiratory Society recommends Amoxicillin-clavulanate as the first-line drug of choice for most lower respiratory tract infections, particularly for moderate to severe cases and hospitalized patients 2, 3
For adults without comorbidities or risk factors, the European Respiratory Society recommends Aminopenicillin (Amoxicillin) 3g/day orally 4
Macrolides are the preferred agents for atypical pathogens, according to the European Respiratory Society 5
For suspected atypical pathogens in adults under 40 years without underlying disease, first-line treatment with amoxicillin 3 g/day orally or macrolides (such as azithromycin 500 mg daily for 3 days) is recommended, as suggested by the European Respiratory Society 5, 4

The European Respiratory Society recommends considering local resistance patterns when selecting therapy, and ensuring coverage for the most likely pathogens based on clinical presentation 2, 3
Antibiotic selection should be guided by local resistance patterns, patient allergies, and previous antibiotic exposure, particularly for fluoroquinolones 3
The European Respiratory Society recommends a treatment duration of typically 5-7 days for most LRTIs 4
Patients should be instructed to return if fever doesn't resolve within 48 hours, and treatment should continue for at least 48-72 hours beyond symptom resolution 4

For P. aeruginosa, the European Respiratory Society recommends Ciprofloxacin or anti-pseudomonal β-lactams 2
For pulmonary abscess or cavitated pneumonia, IV amoxicillin-clavulanate 2 g every 6 hours or second or third-generation cephalosporin plus a macrolide or quinolone may be used, as recommended by the European Respiratory Journal 4
For aspiration pneumonia, coverage for anaerobic bacteria should be considered, with options including clindamycin or beta-lactam/beta-lactamase inhibitors, according to the European Society of Clinical Microbiology and Infectious Diseases and the European Respiratory Society 4, 3

The European Respiratory Society suggests alternatives such as Tetracycline, Oral cephalosporin, Macrolides, and 3rd generation quinolones (levofloxacin, moxifloxacin) for lower respiratory tract infections 2
Respiratory fluoroquinolones (e.g., ciprofloxacin 500 mg twice daily plus metronidazole) are a second-line option for lower body infections, as recommended by the European Respiratory Journal 4
Ampicillin plus gentamicin plus metronidazole is a second-line option for lower body infections, according to the Clinical Microbiology and Infection guidelines 6
Meropenem (for severe infections not responding to first-line therapy) is a second-line option for lower body infections, as recommended by the Clinical Microbiology and Infection guidelines 6

Severe disease at presentation is a risk factor for treatment failure, according to the European Respiratory Journal 4
Premature discontinuation of antibiotics may lead to treatment failure and recurrence, as noted by the European Respiratory Journal 4
Switching from azithromycin to an alternative antibiotic should be considered if there is no clinical improvement after 72 hours of appropriate therapy, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 7
If no improvement is seen after 72 hours, alternative antibiotics should be considered, as recommended by the European Respiratory Journal 4